Bahrain is actively participating in the UAE's phase III clinical trials for the COVID-19 vaccine.
According to Ashish Koshy, the CEO of G42 Healthcare, Bahrain is working on enrolling and vaccinating close to 6,000 volunteers.
He clarified that this expansion enforces the ongoing collaboration between the two countries.
Speaking to ARN News, Koshy revealed that there will be more collaborations in the future.
He explained that the current trials have also shown positive results so far.


UAE Cabinet approves AED 292.5 billion for 2027-2029
Etihad Airways cancels more flights to Saudi Arabia
Dubai arrests group over fake Google reviews targeting company
UAE to train 50 young content creators on water sustainability
